VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis

Abstract

BACKGROUNDPrior data suggest that vancomycin-resistant Enterococcus (VRE) bacteremia is associated with worse outcomes than vancomycin-sensitive Enterococcus (VSE) bacteremia. However, many studies evaluating such outcomes were conducted prior to the availability of effective VRE therapies.OBJECTIVETo systematically review VRE and VSE bacteremia outcomes among hospital patients in the era of effective VRE therapy.METHODSElectronic databases and grey literature published between January 1997 and December 2014 were searched to identify all primary research studies comparing outcomes of VRE and VSE bacteremias among hospital patients, following the availability of effective VRE therapies. The primary outcome was all-cause, in-hospital mortality, while total hospital length of stay (LOS) was a secondary outcome. All meta-analyses were conducted in Review Manager 5.3 using random-effects, inverse variance modeling.RESULTSAmong all the studies reviewed, 12 cohort studies and 1 case control study met inclusion criteria. Similar study designs were combined in meta-analyses for mortality and LOS. VRE bacteremia was associated with increased mortality compared with VSE bacteremia among cohort studies (odds ratio [OR], 1.80; 95% confidence interval [CI], 1.38–2.35; I2=0%; n=11); the case-control study estimate was similar, but not significant (OR, 1.93; 95% CI, 0.97–3.82). LOS was greater for VRE bacteremia patients than for VSE bacteremia patients (mean difference, 5.01 days; 95% CI, 0.58–9.44]; I2=0%; n=5).CONCLUSIONSDespite the availability of effective VRE therapy, VRE bacteremia remains associated with an increased risk of in-hospital mortality and LOS when compared to VSE bacteremia.Infect. Control Hosp. Epidemiol. 2015;37(1):26–35

Prevalence of vancomycin-resistant Enterococcus in Iran: a systematic review and meta-analysis

“…Enterococcus is a common commensal bacterium originating from the human gastrointestinal tract and may cause serious infections in humans under certain conditions [1]. Enterococci constitute the second most common cause of nosocomial urinary tract infections [2].…”

Rates of blood cultures positive for vancomycin-resistant Enterococcus in Ontario: a quasi-experimental study

“…[4][5][6][7][8] Patients with bacteremia due to VRE are thought to have worse outcomes than patients with vancomycinsusceptible enterococcal bacteremia, including increased mortality and length of hospital stay. 9 Preventing nosocomial VRE infections is therefore a patient safety priority in many jurisdictions. [10][11][12][13] In an effort to minimize the spread of antimicrobial resistance within hospitals, it is widely recommended to emphasize hand hygiene, environmental cleaning and antimicrobial stewardship (including control of vancomycin use).…”

Update on infection control practices in cancer hospitals

“…VREs usually are not highly pathogenic and tend to cause more colonization than infection. However, in a recent meta‐analysis that included adult and pediatric patients diagnosed with VRE infection, VRE was associated with an increase in hospital mortality, even in a nonimmunocompromised population . VRE colonization rates in HCT recipients are 6% to 40% at admission, and VRE colonization has been associated with an increased risk for VRE BSIs .…”